Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;13(6):1407-1416.
doi: 10.1007/s40123-024-00953-8. Epub 2024 May 5.

Home Optical Coherence Tomography Monitoring for Neovascular Age-Related Macular Degeneration: Transformative Technology or Cool Toy?

Ethan T Willis  1   2 , Judy E Kim  3 , Eric W Schneider  4
Affiliations

Home Optical Coherence Tomography Monitoring for Neovascular Age-Related Macular Degeneration: Transformative Technology or Cool Toy?

Ethan T Willis et al. Ophthalmol Ther. 2024 Jun.

Abstract

The pending introduction of home-based optical coherence tomography (OCT) in managing neovascular age-related macular degeneration (nAMD) has sparked interesting debates. Advocates assert that home-based OCT will revolutionize care of patients with nAMD, while skeptics question its real-world viability and point out its potential drawbacks. This article delves into the dichotomy, presenting the "pro" argument highlighting the transformative potential of home OCT and the "con" perspective, which scrutinizes the limitations and challenges to adapting the technology to the real-world setting. By exploring both sides of the discourse, we aim to address the promises and complexities surrounding the role of home OCT in the management of nAMD.

Keywords: Anti-VEGF therapy; Home-based OCT; Neovascular age-related macular degeneration (nAMD); Optical coherence tomography (OCT); Telemonitoring.

PubMed Disclaimer

Conflict of interest statement

Ethan T. Willis: None. Judy E. Kim: Advisory Board/Consultant – Allergan, Amgen, Apellis, Bausch&Lomb, Clearside Biomedical, Coherus, Dutch Ophthalmic Research Center, Eyepoint, Genentech/Roche, Notal Vision, Outlook Therapeutics, Regeneron. Eric W. Schneider: Consultant – Apellis, Carl Zeiss Meditec, Notal Vision, Iveric Bio.

References

    1. Bressler SB. Introduction: understanding the role of angiogenesis and antiangiogenic agents in age-related macular degeneration. Ophthalmology. 2009;116:S1–7. doi: 10.1016/j.ophtha.2009.06.045. - DOI - PubMed
    1. Schmidt-Erfurth U, Klimscha S, Waldstein SM, Bogunović H. A view of the current and future role of optical coherence tomography in the management of age-related macular degeneration. Eye (Lond) 2017;31:26–44. doi: 10.1038/eye.2016.227. - DOI - PMC - PubMed
    1. AREDS2-HOME Study Research Group, Chew EY, Clemons TE, et al. Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study. Ophthalmology. 2014;121:535–544. - PMC - PubMed
    1. Ho AC, Heier JS, Holekamp NM, et al. Real-world performance of a self-operated home monitoring system for early detection of neovascular age-related macular degeneration. J Clin Med. 2021;10:1355. doi: 10.3390/jcm10071355. - DOI - PMC - PubMed
    1. von der Burchard C, Moltmann M, Tode J, et al. Self-examination low-cost full-field OCT (SELFF-OCT) for patients with various macular diseases. Graefes Arch Clin Exp Ophthalmol. 2021;259:1503–1511. doi: 10.1007/s00417-020-05035-6. - DOI - PMC - PubMed

LinkOut - more resources